Verity Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Sell |
11,794
-12,446
| -51% | -$1.38M | 0.62% | 44 |
|
|
2025
Q1 | $2.72M | Buy |
24,240
+12,383
| +104% | +$1.39M | 1.11% | 18 |
|
|
2024
Q4 | $1.1M | Buy |
11,857
+997
| +9% | +$92.1K | 0.62% | 41 |
|
|
2024
Q3 | $911K | Buy |
10,860
+2,066
| +23% | +$173K | 0.34% | 80 |
|
|
2024
Q2 | $603K | Buy |
8,794
+123
| +1% | +$8.44K | 0.24% | 92 |
|
|
2024
Q1 | $635K | Sell |
8,671
-60
| -0.7% | -$4.4K | 0.35% | 73 |
|
|
2023
Q4 | $707K | Buy |
8,731
+168
| +2% | +$13.6K | 0.45% | 58 |
|
|
2023
Q3 | $642K | Buy |
8,563
+948
| +12% | +$71K | 0.47% | 61 |
|
|
2023
Q2 | $587K | Sell |
7,615
-109
| -1% | -$8.4K | 0.44% | 70 |
|
|
2023
Q1 | $641K | Sell |
7,724
-287
| -4% | -$23.8K | 0.38% | 79 |
|
|
2022
Q4 | $688K | Sell |
8,011
-4,384
| -35% | -$376K | 0.59% | 57 |
|
|
2022
Q3 | $765K | Buy |
+12,395
| New | +$765K | 0.79% | 41 |
|
|
2022
Q1 | $673K | Buy |
11,316
+3,904
| +53% | +$232K | 0.43% | 73 |
|
|
2021
Q4 | $538K | Sell |
7,412
-7,743
| -51% | -$562K | 0.32% | 96 |
|
|
2021
Q3 | $1.06M | Buy |
15,155
+247
| +2% | +$17.3K | 0.69% | 32 |
|
|
2021
Q2 | $1.03M | Buy |
14,908
+4,254
| +40% | +$293K | 0.56% | 39 |
|
|
2021
Q1 | $689K | Buy |
10,654
+2,208
| +26% | +$143K | 0.41% | 72 |
|
|
2020
Q4 | $492K | Sell |
8,446
-1,044
| -11% | -$60.8K | 0.34% | 80 |
|
|
2020
Q3 | $600K | Buy |
9,490
+2,553
| +37% | +$161K | 0.46% | 50 |
|
|
2020
Q2 | $500K | Buy |
6,937
+3,195
| +85% | +$230K | 0.46% | 55 |
|
|
2020
Q1 | $280K | Buy |
+3,742
| New | +$280K | 0.35% | 89 |
|
|
2015
Q4 | – | Sell |
-2,614
| Closed | -$257K | – | 82 |
|
|
2015
Q3 | $257K | Buy |
+2,614
| New | +$257K | 0.26% | 65 |
|